Key 3D Printed Drugs Market Players:
- Extend Biosciences
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bioduro
- Affinity Therapeutics
- Osmotica Pharmaceuticals
- Acrux
- Thiomatrix
- Ico Therapeutics Inc.
- Formac Pharmaceuticals
- BiopharmX
- Pacira Pharmaceuticals Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of 3D printed drugs is estimated at USD 118.84 million.
3D Printed Drugs Market size was valued at USD 105.24 million in 2024 and is set to exceed USD 433.22 million by 2034, registering over 15.2% CAGR during the forecast period i.e., between 2025-2034.
North America is poised to account for largest industry share by 2034.
The key market players include Extend Biosciences, Bioduro, Affinity Therapeutics, Osmotica Pharmaceuticals, Acrux, Thiomatrix, Ico Therapeutics Inc., Formac Pharmaceuticals, BiopharmX, Pacira Pharmaceuticals Inc.
